- Home
- Products
- Customized FluoroAb™
- IFNG
- Anti-IFNG MAb (Clone 1)-iFluor® 405 Succinimidyl Ester
Anti-IFNG MAb (Clone 1)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS2145)
- TARGET
- ANTIBODY
- DYE
- Name
- IFNG
- Alternative Names
- GD2
- Overview
- GD2 is a disialoganglioside expressed in tumors of neuroectodermal origin (including human neuroblastoma and melanoma), and its expression in normal tissues (mainly human cerebellum and peripheral nerves) is highly restricted.
The relative tumor-specific expression of GD2 makes it a suitable target for immunotherapy using monoclonal antibodies or artificial T cell receptors. An example of such an antibody is hu14.18K322A, a monoclonal antibody. The anti-GD2 antibody is currently in phase II clinical trials for the treatment of previously untreated high-risk neuroblastoma and combined chemotherapy prior to stem cell transplantation and radiation therapy. A previous phase I clinical trial designed to reduce toxicity in patients with refractory or recurrent neuroblastoma found a safe dose and determined that common toxicity, especially pain, can be well controlled.
- Overview
- Humanized Anti-IFNG IgG1 antibody (Clone 1)
- Species Reactivity
- Human
- Name
- iFluor® 405 Succinimidyl Ester
- Color
- Blue
- Excitation⁄Emission (nm)
- 403/427
- Detection method
- Fluorescent
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS2145. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-1226 | Anti-IFNG (Crenezumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-1228 | Anti-IFNG (Crenezumab)-MC-MMAF ADC | MC (maleimidocaproyl) | MMAF |
| ADC-W-1229 | Anti-IFNG (Crenezumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
| ADC-W-1227 | Anti-IFNG (Crenezumab)-SPDB-DM4 ADC | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
| ADC-W-1230 | Anti-IFNG (Crenezumab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-CD2 MAb (Clone 11)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS1108)
- Anti-APP MAb (Clone 7)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS115)
- Anti-CD5 MAb (Clone 7)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS4272)
- Anti-TNFRSF9 MAb (Clone 12)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS15374)
- Anti-C-kit MAb (Clone 6)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS4886)
- Anti-EDA MAb (Clone 9)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8682)
- Anti-TNFSF13B MAb (Clone 3)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS1684)
- Solanezumab-iFluor 532 (CAT#: ADC-FL-148)
- Mogamulizumab-iFluor 555 (CAT#: ADC-FL-330)
- Anti-TNFRSF17 MAb (Clone 28)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS7103)
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
